Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

Exclusion Criteria

• •Infection, local to the operative site
• •Signs of local inflammation
• •Fever or leukocytosis
• •Morbid obesity
• •Pregnancy
• •Paediatric cases, or patient still having general skeletal growth
• •Spondylolisthesis unable to be reduced to Grade I
• •Suspected or documented allergy or intolerance to metal
• •Any case where the implant components selected for use would be too large or too small to achieve a successful result
• •Any patient having inadequate tissue coverage over the operative site or inadequate bone stock or quality
• •Any patient in which implant utilization would interfere with anatomical structures or expected physiological performance
• •Prior fusion at the level to be treated
• •Any case not needing a bone graft or fusion
• •Any abnormality present which affects the normal process of bone remodelling including, but not limited to severe osteoporosis involving spine, bone absorption, osteopenia, primary or metastasis tumours involving the spine, active infection at the site or certain metabolic disorders affecting osteogenesis
• •Any other condition which would preclude the potential benefit of spinal implant surgery, such as the presence of tumours or congenital abnormalities, fracture local to operating site, elevation of segmentation rate unexplained by other diseases, elevation of white blood count (WBC), or marked left shift in the WBC differential count
• •Mental illness
• •Any patient unwilling to cooperate with postoperative instructions